The scientific article "Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson's Disease" was published in the international refereed journal "Cell Transplantation".

The author of the paper is Leila Karim (Ph.D. in Psychology and Public Health), a professor at the Caucasus School of Medicine and Healthcare Management and RMIT University (Melbourne, Australia).

See the article link.

Polgar S, Finkelstein DI, Karimi L. Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson’s Disease. Cell Transplantation. 2024;33. doi:10.1177/09636897241246355

The journal "Cell Transplantation" is indexed in the SCOPUS (Elsevier) international scientific database by Elsevier, with a CiteScore of 6.8, placing it in the A-level classification.

See https://www.scopus.com/sourceid/18477

The quest for new and improved therapies for Parkinson’s disease (PD) remains of paramount importance. There is a current debate regarding the potential of stem cell research as an approach for PD. The studies of dopaminergic fetal stem cells for PD treatment were reviewed in this study. Research validates cell replacement strategies for human brain reconstruction. While some researchers argue that the considerable technical challenges associated with cell therapies for PD warrant the discontinuation of further development using stem cells, we believe that the opposing viewpoints are instrumental in identifying a series of methodological misunderstandings. Here, we propose to expose key challenges to ensure the advancement of the field and unlock the potential of stem cell therapies in PD treatment. Overall, this review underscores the need for further research and innovation to overcome the hurdles in realizing the potential of stem cell–based therapies for PD.

Caucasus University Healthcare Policy Center.